Aashka Hospitals Closes Trading Window for FY26 Results

Aashka Hospitals Ltd. has begun a trading window closure effective April 1, 2026. This routine step is a regulatory requirement to ensure compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of the company's audited financial results for the fiscal year ending March 31, 2026.

Today's Announcement

The company has officially informed all designated persons, connected persons, and their immediate relatives that they are prohibited from trading Aashka Hospitals' shares. This restriction starts on Wednesday, April 1, 2026.

Why This Matters

This closure is a standard procedure designed to prevent insider trading. It stops individuals with access to Unpublished Price Sensitive Information (UPSI) about the upcoming financial results from trading shares, ensuring a level playing field for all investors.

Company Background and Performance

Aashka Hospitals, a Gandhinagar-based healthcare provider, has faced significant growth challenges. Its revenue has seen a compound annual growth rate (CAGR) of -0.25% over the last five years, unlike the industry average of 24.67%. Its market share has also declined from 1.3% to 0.36% in the same period.

Recent financials for the half-year ended September 30, 2025, showed a Profit After Tax of INR 78.00 Lakhs, a drop from INR 161.85 Lakhs in the prior year.

Trading Restrictions

Designated employees and their relatives must refrain from trading Aashka Hospitals' shares until the company officially announces its audited FY26 financial results. This period is crucial for safeguarding against any potential misuse of sensitive, non-public information.

Competitive Landscape

Aashka Hospitals operates within a sector dominated by major players such as Apollo Hospitals, Max Healthcare, and Fortis Healthcare. These larger competitors typically demonstrate robust revenue growth and higher revenue per bed metrics, creating a challenging environment for smaller entities.

Investor Considerations

While the trading window closure is a normal corporate practice, investors should remain aware of the company's historical financial performance. Stagnant revenue growth and a declining market share are key factors to monitor.

Key Metrics

• Revenue CAGR (5-year, Standalone): -0.25% (vs. Industry Average: 24.67%)
• Market Share (5-year, Standalone): Declined to 0.36% (from 1.3%)

What's Next

The company is expected to announce the date of its Board Meeting to approve the audited financial results for FY26. Investors should await the official declaration of these results. Typically, the trading window reopens 48 hours after the announcement. The company's performance relative to its peers will be a significant focus post-results.